Clinical Trial Update: Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating abiraterone acetate, niclosamide, and prednisone in hormone-resistant prostate cancer; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Niclosamide (niclosamide)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Mamta Parikh | Conditions: Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING